Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bob Swift who wrote (1874)	3/2/1999 6:24:00 PM
From: Biomaven	Read Replies (1) of 10280

Bob, None of the drugs SEPR is developing have as their only advantage a smaller dose (your case III). They all have one or more of: reduced side effects, quicker onset of action, fewer drug interactions or better efficacy. Thus Xopenex is confirmed to have reduced immediate side effects, and may also have an important advantage for long-term use. If the latter is confirmed it will totally dominate the market; if not it will still take a big share of it. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next